Analyst Research

Report Title Price
Zhejiang Conba Pharmaceutical Co., Ltd. (600572) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
Thomson Reuters Stock Report - ZHEJIANG CONBA PHARMACEUTICAL CO., LTD. (600572-SH)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Zhejiang CONBA Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for Zhejiang Conba Pharmaceutical Co., Ltd.
Provider: Wright Reports
$472.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Zhejiang CONBA Pharmaceutical Co Ltd to Transfer Equity Shares


Thursday, 28 Feb 2013 07:00pm EST 

Zhejiang CONBA Pharmaceutical Co Ltd announced that it will transfer a 25% stake in a Hangzhou-based biological engineering company (Company A) to Company A's largest shareholder, Mr. Feng Jianping for RMB 12,531,646. After that, the Company will still hold a 5% stake in the target company. 

Latest Developments for Zhejiang CONBA Pharmaceutical Co Ltd

Latest Key Developments in Pharmaceuticals

Company Quote

Zhejiang CONBA Pharmaceutical Co Ltd
(600572.SS)
12.73
0.01 +0.08%
24 May 2013